1-20 of 25
Benigno C. Valdez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myeloablative Fractionated Busulfan, Fludarabine, Cladribine, Thiotepa and Venetoclax (Cladillac) Conditioning Regimen for Very High-Risk AML/MDS: A Phase 2 Trial

Uday Popat, Roland L. Bassett, Amin M. Alousi, Gheath Alatrash, Yosra M. Aljawai, Qaiser Bashir, George Chen, Warren B. Fingrut, Chitra Hosing, Jin S. Im, Partow Kebriaei, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Muzaffar H. Qazilbash, Jeremy Ramdial, Neeraj Y. Saini, Portia Smallbone, Samer A. Srour, Benigno C. Valdez, Richard E. Champlin, Borje S. Andersson, Elizabeth J. Shpall
Journal: Blood
Blood (2024) 144 (Supplement 1): 506.
https://doi.org/10.1182/blood-2024-203338
Published: 2024
Journal Articles

Post-Allograft Romidepsin Maintenance Mitigates Relapse Risk and Stimulates the Graft-Versus-Malignancy Effect through Enhanced NK-Cell Cytotoxicity in Patients with T-Cell Malignancies: Final Results of a Phase I/II Trial

Chitra Hosing, Zachary Braunstein, Eric McLaughlin, Benigno C. Valdez, Borje S. Andersson, Uday R. Popat, Sumithira Vasu, Evandro Bezzera, Gabriela Sanchez-Petitto, Sarah A Wall, Samantha M. Jaglowski, Sam Penza, Hannah Choe, Lai Wei, Robin Nakkula, Alex Cash, Richard E. Champlin, Marcos de Lima, Steven M. Devine, Dean Anthony Lee, Jonathan E. Brammer
Journal: Blood
Blood (2023) 142 (Supplement 1): 184.
https://doi.org/10.1182/blood-2023-190213
Published: 2023
Journal Articles

Post-Allograft Romidepsin Maintenance Mitigates Relapse Risk and Stimulates the Graft-Versus-Malignancy Effect through Enhanced NK-Cell Cytotoxicity in Patients with Aggressive T-Cell Malignancies in a Phase I/II Trial

Chitra Hosing, Eric McLaughlin, Zachary Braunstein, Benigno C Valdez, Lai Wei, Uday R Popat, Borje S Andersson, Sumithira Vasu, Karilyn T. Larkin, Samantha Jaglowski, Sam Penza, Ayman Saad, Hannah Choe, Sarah A Wall, Alex Cash, Robin Nakkula, Richard E Champlin, Marcos J.G. de Lima, Dean Anthony Lee, Jonathan E Brammer
Journal: Blood
Blood (2022) 140 (Supplement 1): 1885–1886.
https://doi.org/10.1182/blood-2022-169336
Published: 2022
Journal Articles

High Efficacy of the PARP Inhibitor Olaparib Combined with High-Dose Chemotherapy and Autologous Stem-Cell Transplant for Refractory Lymphomas

Yago Nieto, Benigno C Valdez, Peter F Thall, Jeremy L. Ramdial, Samer A Srour, Chitra Hosing, Neeraj Saini, Amin M Alousi, Muzaffar H Qazilbash, Uday R Popat, Alison Gulbis, Terri Lynn Shigle, Roland Bassett, Maria Guillermo-Pacheco, Celina Ledesma, Paolo Strati, Sairah Ahmed, Raphael Steiner, Jason Westin, Ranjit Nair, Swaminathan P. Iyer, Richard E Champlin, Elizabeth J Shpall, Borje S Andersson
Journal: Blood
Blood (2022) 140 (Supplement 1): 1183–1184.
https://doi.org/10.1182/blood-2022-156121
Published: 2022
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen with Sorafenib in Patients with AML: Results of Phase I Clinical Trial

Uday R. Popat, Roland Bassett, Peter F. Thall, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Naval Daver, Farhad Ravandi, Elizabeth J. Shpall, Richard E. Champlin, Borje S. Andersson, Rohtesh S. Mehta
Journal: Blood
Blood (2021) 138 (Supplement 1): 556.
https://doi.org/10.1182/blood-2021-152450
Published: 2021
Journal Articles

Romidepsin in Conditioning and Maintenance Mitigates Relapse Risk and Enhances NK-Cell Cytotoxicity in Patients Receiving Allogeneic Stem Cell Transplant for Aggressive T-Cell Malignancies: Results of a Phase I/II Clinical Trial

Chitra Hosing, Zachary Braunstein, Alaa M Ali, Benigno C. Valdez, Borje S. Andersson, Uday R. Popat, Sumithira Vasu, Karilyn Larkin, Sam Penza, Hannah Choe, Ayman Saad, Marcos J.G. de Lima, Lai Wei, Eric McLaughlin, Robin Nakkula, Amanda Campbell, Prashant Trikha, Marcin Puto, Basem M. William, Richard E. Champlin, Dean Anthony Lee, Jonathan E Brammer
Journal: Blood
Blood (2021) 138 (Supplement 1): 553.
https://doi.org/10.1182/blood-2021-152833
Published: 2021
Journal Articles

Post-Transplant Cyclophosphamide Versus Tacrolimus and Methotrexate to Prevent Graft-Versus-Host Disease in Recipients of Matched Donor Transplantation: Comparison of Sequential Cohorts in a Prospective Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Jitesh D. Kawedia, Issa F. Khouri, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Tapan M. Kadia, Hagop Kantarjian, Elizabeth J. Shpall, Richard E. Champlin, Borje S. Andersson
Journal: Blood
Blood (2021) 138 (Supplement 1): 1803.
https://doi.org/10.1182/blood-2021-146245
Published: 2021
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen with Venetoclax in Patients with AML/MDS: Prospective Phase II Clinical Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Alison Gulbis, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Tapan M. Kadia, Marina Konopleva, Elizabeth J. Shpall, Borje S. Andersson, Richard E. Champlin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2879.
https://doi.org/10.1182/blood-2021-146253
Published: 2021
Journal Articles

A Randomized Study of Pretransplant Conditioning Therapy for AML/MDS with Fludarabine ± Clofarabine and Once Daily IV Busulfan with Allogeneic Hematopoietic Transplantation for AML and MDS

Borje S. Andersson, MD, PhD, Peter Thall, Benigno C. Valdez, PhD, Junsheng Ma, MS, Julianne Chen, Sairah Ahmed, MD, Amin M. Alousi, MD, Qaiser Bashir, MD, Stefan O. Ciurea, MD, Alison Gulbis, Chitra Hosing, MD, Roy B. Jones, MD PhD, Jitesh Kawedia, BPharm, Partow Kebriaei, MD, Steven M. Kornblau, MD, Alan Myers, PharmD, PhD RPh, Betul Oran, MDMS, Katayoun Rezvani, MD PhD, Nina Shah, MD, Elizabeth J. Shpall, MD, Simrit Parmar, MD, MSCI, Uday R. Popat, MD, Yago Nieto, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-142680
Published: 2020
Journal Articles

High-Dose Chemotherapy (HDC) with Autologous Stem-Cell Transplant (ASCT) with Consolidative Radiation Therapy (RT) for Relapsed or Refractory (R/R) Primary Mediastinal B-Cell Lymphoma (PMBCL): 20-Year Experience at MD Anderson Cancer Center (MDACC)

Neeraj Saini, MD, Junsheng Ma, MS, Melissa Timmons, PA-C, Amin M. Alousi, MD, Paolo Anderlini, Borje S. Andersson, MD, PhD, Chitra Hosing, MD, Jeremy Ramdial, MD, Partow Kebriaei, MD, Uday R. Popat, MD, Muzaffar H. Qazilbash, MD, Elizabeth J. Shpall, MD, Samer A. Srour, MD MS, Benigno C. Valdez, PhD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD PhD, Jillian R. Gunther, MD PhD, Farzaneh Maadani, BS, MT, Gabriela Rondon, Richard E. Champlin, MD, Yago Nieto, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-134471
Published: 2020
Journal Articles

Factors Associated with the Improvement of Outcomes of High-Risk Relapsed Hodgkin Lymphoma (HL) Patients Receiving High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT): The MD Anderson Cancer Center Experience

Yago Nieto, MD, Stephen K. Gruschkus, PhD MPH, Roy B. Jones, MD PhD, Benigno C. Valdez, PhD, Melissa Timmons, PA-C, Chitra Hosing, MD, Paolo Anderlini, Partow Kebriaei, MD, Uday R. Popat, MD, Muzaffar H. Qazilbash, MD, Amin M. Alousi, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Jeremy Ramdial, MD, Jin S. Im, Elizabeth J. Shpall, MD, Katayoun Rezvani, MD PhD, Alison Gulbis, Terri Lynn Shigle, PharmD, Kris Michael Mahadeo, MD, Sajad Khazal, MD, Issa F. Khouri, MD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD PhD, Jillian R. Gunther, MD PhD, Hun Lee, MD, Sairah Ahmed, MD, Raphael Eric Steiner, MD, Swaminathan P Iyer, MD, Ranjit Nair, MD, Simrit Parmar, MD, MSCI, Branko Cuglievan, MD, Farzaneh Maadani, BS, MT, Gabriela Rondon, Richard E. Champlin, MD, Borje S. Andersson, MD, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-139880
Published: 2020
Journal Articles

Myeloablative Fractionated Busulfan with Fludarabine in Older Patients: Long Term Outcomes of Prospective Phase II Clinical Trial

Rohtesh S. Mehta, MDMPH,MS, Roland Bassett, Julianne Chen, Benigno C. Valdez, PhD, Jitesh Kawedia, BPharm, Amin M. Alousi, MD, Gheath Alatrash, Qaiser Bashir, MD, Stefan Ciurea, MD, Chitra Hosing, MD, Jin S. Im, Partow Kebriaei, MD, Amanda L. Olson, Betul Oran, MDMS, Muzaffar H. Qazilbash, MD, Samer A. Srour, MD MS, Elizabeth J. Shpall, MD, Borje S. Andersson, MD, PhD, Richard E. Champlin, MD, Uday R. Popat, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-139325
Published: 2020
Journal Articles

A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS

Richard E. Champlin, MD, Uday Popat, MD, Betul Oran, MDMS, Stefan O. Ciurea, MD, Partow Kebriaei, MD, Amin M. Alousi, MD, Gheath Alatrash, DO, PhD, Qaiser Bashir, MBBS, Issa F. Khouri, MD, Chitra Hosing, MD, Paolo Anderlini, Roy B Jones, MD PhD, David Marin, MD, Rohtesh Mehta, MD, Yago Nieto, MD PhD, Amanda L. Olson, MD, Muzaffar H. Qazilbash, MD, Katy Rezvani, MD PhD, Elizabeth J. Shpall, MD, Julianne Chen, Gabriela Rondon, MD, Becky McMullin, Vivian P Al Jahdhami, RN, Jitesh Kawedia, BPharm, Benigno C. Valdez, PhD, Junsheng Ma, MS, Peter F Thall, Borje S Andersson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 257.
https://doi.org/10.1182/blood-2019-124921
Published: 2019
Journal Articles

Decitabine As Part of a Modified Bu-Cy Conditioning Regimen Significantly Improved the Outcome of High-Risk AML Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Xiaowen Tang, Benigno C. Valdez, PhD, Qianqian Zhang, Yunju Ma, Haiping Dai, Jia Yin, Zheng Li, Ting Xu, Yang Xu, MD PhD, Jia Chen, Xiaming Zhu, Depei Wu, MD PhD, Borje S Andersson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3270.
https://doi.org/10.1182/blood-2019-123951
Published: 2019
Journal Articles

Gemcitabine/Clofarabine/Busulfan: A New Myeloablative Reduced-Toxicity Conditioning Regimen with High Activity for Allogeneic Stem-Cell Transplant (alloSCT) in Aggressive Lymphomas

Yago Nieto, MD PhD, Peter F Thall, Benigno C Valdez, PhD, Junsheng Ma, MS, Melissa Timmons, Michelle Trapp, Sairah Ahmed, MD, Elizabeth J Shpall, MD, Roy B Jones, MDPhD, Chitra Hosing, MD, Paolo Anderlini, Uday Popat, MD, Muzaffar H. Qazilbash, MD, Amin Alousi, MD, Alison M Gulbis, PharmD, Celina Ledesma, Richard E. Champlin, MD, Borje S Andersson, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1966.
https://doi.org/10.1182/blood.V130.Suppl_1.1966.1966
Published: 2017
Journal Articles

A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma

Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD MBBS, Peter F Thall, Denái R. Milton, Nina Shah, MD, Krina K. Patel, MDMSc, Borje S Andersson, MDPhD, Yago Nieto, MD PhD, Partow Kebriaei, MD, Benigno C. Valdez, PhD, Jitesh Kawedia, BPharm, Simrit Parmar, MBBS, Ruby Delgado, Sairah Ahmed, MD, Chitra Hosing, MD, Uday Popat, MD, Elizabeth J Shpall, MD, Donna M. Weber, MD, Sheeba K. Thomas, MD, Elisabet E. Manasanch, MD, Hans C. Lee, MD, Robert Z. Orlowski, MD PhD, Richard E Champlin, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 399.
https://doi.org/10.1182/blood.V130.Suppl_1.399.399
Published: 2017
Journal Articles

Busulfan (Bu) in Combination with Double Nucleoside Analogues Fludarabine (Flu) and Clofarabine (Clo) Plus Vorinostat As a Novel Reduced Toxicity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients (pts) with Acute Leukemia

Partow Kebriaei, MD, Wei Wei, MS, Peter F Thall, PhD, Celina Ledesma, BS, Benigno C. Valdez, PhD, Uday R. Popat, MD, Amanda L. Olson, MD, Amin M. Alousi, MD, Betul Oran, MD, Sairah Ahmed, MD, Stefan O. Ciurea, MD, Krina Patel, MD, Elizabeth J. Shpall, MD, Chitra Hosing, MD, Muzaffar H Qazilbash, MD, Nina Shah, MD, David Marin, MD, Katayoun Rezvani, MD PhD, Yago Nieto, MD PhD, Richard E. Champlin, MD, Borje S Andersson, MD PhD
Journal: Blood
Blood (2016) 128 (22): 64.
https://doi.org/10.1182/blood.V128.22.64.64
Published: 2016
Journal Articles

Double Epigenetic Modulation of High-Dose Chemotherapy (HDC) with Autologous Stem-Cell Transplant (ASCT) for Patients with Refractory or Poor-Risk Relapsed Lymphoma

Yago Nieto, MD, PhD, Benigno C. Valdez, PhD, Peter F Thall, PhD, Wei Wei, MS, Roy Jones, MD PhD, Chitra M. Hosing, MD, Sairah Ahmed, MD, Uday R. Popat, MD, Elizabeth J. Shpall, MD, Muzaffar Qazilbash, MD, Alison M Gulbis, Paolo Anderlini, MD, Nina Shah, MD, Qaiser Bashir, MD, Amin M. Alousi, MD, Yasuhiro Oki, MD, Fredrick B. Hagemeister, MD, Richard E. Champlin, MD, Borje S. Andersson, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1992.
https://doi.org/10.1182/blood.V126.23.1992.1992
Published: 2015
Journal Articles

Prospective Phase 2 Trial of High-Dose Gemcitabine/Busulfan/Melphalan (Gem/Bu/Mel) with Autologous Stem-Cell Transplant (ASCT) without Post-ASCT Maintenance, in Hodgkins Lymphoma Patients at High Risk of Post-Transplant Recurrence Comparison with a Concurrent Matched Cohort Treated with BEAM

Yago Nieto, MD, PhD, Roland Bassett, MS, Paolo Anderlini, MD, Chitra M. Hosing, MD, Amin M. Alousi, MD, Uday R. Popat, MD, Borje S. Andersson, MD PhD, Benigno C. Valdez, PhD, Elizabeth J. Shpall, MD, Sairah Ahmed, MD, Muzaffar Qazilbash, MD, Maria Guillermo, Yasuhiro Oki, MD, Michelle A. Fanale, Fredrick B. Hagemeister, MD, Bouthaina S. Dabaja, MD, Chelsea C Pinnix, MDPhD, Sarah A Milgrom, MD, Priti Tewari, MD, Richard E. Champlin, MD, Roy Jones, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1980.
https://doi.org/10.1182/blood.V126.23.1980.1980
Published: 2015
Journal Articles

Eltrombopag for Post-Transplant Thrombocytopenia: Results of Phase II Randomized Double Blind Placebo Controlled Trial

Uday R. Popat, MD, Genevieve Ray, Roland L Bassett, Jr., Man-Yin C Poon, Benigno C. Valdez, PhD, Sergej Konoplev, MD PhD, Sairah Ahmed, MD, Amin M. Alousi, MD, Borje Andersson, MD PhD, Qaiser Bashir, MD, Stefan O. Ciurea, MD, Chitra M. Hosing, MD, Roy Jones, MD PhD, Partow Kebriaei, MD, Issa F. Khouri, MD, Stella Kim, Yago Nieto, MD PhD, Amanda L. Olson, MD, Betul Oran, MD, Simrit Parmar, MD, Muzaffar H. Qazilbash, MD, Katy Rezvani, MD PhD, Nina Shah, MD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2015) 126 (23): 738.
https://doi.org/10.1182/blood.V126.23.738.738
Published: 2015